ASCO: New ASCO guideline on selection of germline Genetic Testing panels

Heidi Ko, Medical director of medical affairs at Labcorp oncology, shared a post by ASCO, on LinkedIn:

“Thank you American Society of Clinical Oncology (ASCO) for providing guidance on selection of how and what to test for when deciding on germline genetic testing in patients with cancer.

Other important clinical questions were also addressed:

Which components of family history are most important to collect
Who should be offered germline testing based on his/her tumor biomarker test results.”

Quoting ASCO‘s post:

“Just issued: New ASCO guideline on selection of germline Genetic Testing panels in patients with cancer. ”

Source: Heidi Ko/LinkedIn and ASCO/LinkedIn